On May 12, 2026, after an eleven-year global consensus process involving roughly 22,000 patients, clinicians, and researchers, polycystic ovary syndrome (PCOS) was formally renamed polyendocrine metabolic ovarian syndrome (PMOS). It was published in The Lancet and is rolling out worldwide.
The old name pointed at the wrong thing. You do not need ovarian cysts to have this condition, and many women who have it never develop them. By leading with the word polycystic, the name reduced a whole-body hormonal and metabolic disorder to a problem with the ovaries. That framing has consequences. It is part of why PMOS is so often missed, treated as a fertility issue alone, or managed one symptom at a time while the metabolic picture underneath goes unexamined.
Because that picture is the point. PMOS affects blood sugar and insulin, cardiovascular risk, weight, skin, mood, and the reproductive system. It affects as many as one in eight women, which makes it one of the most common hormonal conditions there is. Care that looks only at cycles, or only at the ovaries, is seeing a fraction of it.
This is what we built SPHERE HEALTH around. Understanding PMOS means reading the endocrine and metabolic markers together rather than in isolation, which is why a board-certified OB-GYN reviews screening labs spanning blood sugar, androgens, thyroid, and reproductive hormones, and follows how they move over time. The condition is named for the whole body now. The care should match.
If you were diagnosed with PCOS, you have PMOS. Nothing about your body changed. The name did, and with it, the standard of attention it should have had all along.
This is educational and not medical advice. For guidance on your own health, talk with a board-certified OB-GYN.
SPHERE HEALTH is an evidence-based virtual women’s health care platform built around board-certified OB-GYNs, launching soon. Subscribe to follow along, and join the waitlist at spherehealth.com.
Share
